Publications & Posters

Research that inspires, data that informs, and knowledge that empowers.

We are proud to contribute to the latest immunology and inflammation research through scientific publications and medical meetings.

November 2023

EVO756 is a novel MRGPRX2 antagonist that potently inhibits human mast cell degranulation in response to multiple agonists – a potential treatment for CSU and beyond

November 2023

Role of MRGPRs in substance P signaling, itch, and mast cell activation

We have a range of chronic inflammatory disease programs currently in development.